Administration of crushed maraviroc via percutaneous gastrostomy tube in a patient with human immunodeficiency virus and progressive multifocal leukoencephalopathy-Reference-Cited by-同舟云学术

Administration of crushed maraviroc via percutaneous gastrostomy tube in a patient with human immunodeficiency virus and progressive multifocal leukoencephalopathy

Published:2019-02-09 Issue:5 Volume:76 Page:265-267
ISSN:1079-2082
Container-title:American Journal of Health-System Pharmacy
language:en
Short-container-title:

Author:

Pecora Fulco Patricia¹,Gatesman Travis L¹

Affiliation:

1. Department of Pharmacy Virginia Commonwealth University Health Richmond, VA

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Link

http://academic.oup.com/ajhp/article-pdf/76/5/265/28791335/zxy046.pdf

Reference14 articles.

1. Acute care management of the HIV-infected patient: a report from the HIV Practice and Research Network of the American College of Clinical Pharmacy;Durham;Pharmacotherapy,2017

2. Decreased absorption of dolutegravir and tenofovir disoproxil fumarate, but not emtricitabine, in an HIV-infected patient following oral and jejunostomy-tube administration;Brooks;Pharmacotherapy,2017

3. A HAART-breaking review of alternative antiretroviral administration: practical considerations with crushing and enteral tube scenarios;Huesgen;Pharmacotherapy,2016

4. Therapeutic drug monitoring of anti-human immunodeficiency virus drugs in a patient with short bowel syndrome;Ikuma;Intern Med,2016

5. Enteral administration of twice-daily dolutegravir and rilpivirine as a part of a triple-therapy regimen in a critically ill patient with HIV;Turley;J Int Assoc Provid AIDS Care,2017

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Crushed bictegravir/emtricitabine/tenofovir alafenamide in a human immunodeficiency virus–positive patient with esophageal cancer;American Journal of Health-System Pharmacy;2020-03-24